Recent News

• 10.15.2026 - ChronoScale Reports Fiscal First Quarter 2027 Results
• 10.15.2026 - ChronoScale Reports Fiscal First Quarter 2027 Results
• 10.01.2026 - ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
• 10.01.2026 - ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
• 09.25.2026 - ARS - Annual Report to Security Holders
• 08.27.2026 - ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America
• 08.27.2026 - ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America
• 08.19.2026 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 08.18.2026 - Nutanix and ChronoScale Announce Strategic Partnership to Accelerate Enterprise AI Adoption
• 06.04.2026 - ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy

Recent Filings

• 10.15.2026 - 8-K Current report
• 10.15.2026 - EX-99.1 EX-99.1
• 10.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.09.2026 - EFFECT Notice of Effectiveness
• 10.06.2026 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.06.2026 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.06.2026 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.06.2026 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.06.2026 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.06.2026 - 4 Statement of changes in beneficial ownership of securities